Inventor profile of:

Arkady MANDEL

City:

North York

Country:

Canada

Published Applications:

22

Last publication date:

2025-12-11

Top Assignees for applications by Arkady MANDEL

The entities that hold a legal rights for patent applications filed by inventor MANDEL Arkady:

Recent patent applications by MANDEL Arkady

Arkady MANDEL from North York, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-11
US20250375511A1
Human necessities

METHOD FOR TREATING CONDITIONS ASSOCIATED WITH HYPERPROLIFERATING CELLS COMPRISING COMBINED ADMINISTRATION OF INFECTIOUS AGENTS AND METAL CATIONS

#2 | 2025-12-11
US20250375458A1
Human necessities

COMPOSITIONS AND METHODS TO COMBAT MULTIDRUG-RESISTANT AND PERSISTENT T-CELL-MEDIATED, ONCOLOGICAL AND INFECTIOUS DISEASES

#3 | 2025-04-10
US20250114456A1
Human necessities

ENHANCED IMMUNOTHERAPEUTIC METHOD COMPRISING COMBINED ADMINISTRATION OF PHOTODYNAMIC / RADIOTHERAPEUTIC COMPOUNDS AND IMMUNOTHERAPEUTIC AGENTS

#4 | 2022-09-22
US20220296709A1
Human necessities

Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents

#5 | 2022-09-08
US20220280529A1
Human necessities

INACTIVATION OF PATHOGENS USING METAL-BASED COORDINATION COMPLEXES, AND METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MICROBIAL AND/OR VIRAL INFECTIONS

#6 | 2019-09-26
US20190290657A1
Human necessities

Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy

#7 | 2008-06-05
US20080131416A1
Human necessities

APOPTOTIC ENTITIES FOR USE IN TREATMENT OF NEURODEGENERATIVE AND OTHER NEUROLOGICAL DISORDERS

#8 | 2008-05-29
US20080124386A1
Human necessities

APOPTOSIS-MIMICKING SYNTHETIC ENTITIES AND USE THEREOF IN MEDICAL TREATMENT

#9 | 2008-03-13
US20080063631A1
Human necessities

APOPTOTIC ENTITIES FOR USE IN TREATMENT OF ENDOTHELIUM DYSFUNCTION DISORDERS

#10 | 2007-10-09
US9866569
-

Apoptotic entities for use in treatment of endothelium dysfunction disorders

#11 | 2007-08-14
US10815509
-

Treatment of endothelin-related disorders

#12 | 2006-11-07
US9871146
-

Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders

#13 | 2006-10-17
US10115943
-

Compositions containing apoptotic entities

#14 | 2006-05-18
US20060105031A1
Human necessities

Accelerating recovery from trauma

#15 | 2006-02-16
US20060035809A1
Human necessities

Apoptosis-mimicking natural vesicles and use thereof in medical treatment

#16 | 2006-01-12
US20060008517A1
Human necessities

Treatment of age-related memory impairment

#17 | 2005-10-11
US9957698
-

Apoptosis-mimicking synthetic entities and use thereof in medical treatment

#18 | 2005-07-07
US20050147660A1
Human necessities

Peptide-carrying bodies for immune response

#19 | 2005-03-24
US20050063995A1
Human necessities

Compositions and methods for selected tumour treatment

#20 | 2005-03-17
US20050058767A1
Human necessities

Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities

#21 | 2005-03-17
US20050058698A1
Human necessities

Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's Disease

#22 | 2005-02-17
US20050037063A1
Human necessities

Combined therapies

InventorID:

2995357 ⎘